Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
By F. Alexis, Eric M. Pridgen, Linda K. Molnar, O. Farokhzad. Molecular Pharmaceutics, 2008
3,544 citations recorded by the source corpus.
Nanoparticle (NP) drug delivery systems (5−250 nm) have the potential to improve current disease therapies because of their ability to overcome multiple biological barriers and releasing a therapeutic load in the optimal dosage range. Rapid clearance of circulating nanoparticles during systemic delivery is a critical issue for these systems and has made it necessary to understand the factors affecting particle biodistribution and blood circulation half-life. In this review, we discuss the factors which can influence nanoparticle blood residence time and organ specific accumulation. These factors include interactions with biological barriers and tunable nanoparticle parameters, such as composition, size, core properties, surface modifications (pegylation and surface charge), and finally, targeting ligand functionalization. All these factors have been shown to substantially affect the biodistribution and blood circulation half-life of circulating nanoparticles by reducing the level of nonspecific uptake, delaying opsonization, and increasing the extent of tissue specific accumulation.
Subfields: Biomaterials
View Paper: https://www.semanticscholar.org/paper/518bf7a34a0c85761f956a74724f21a71c09177a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
Citations in the corpus
- PLGA-based nanoparticles: an overview of biomedical applications. (2012, background): “Functionalization of nanoparticles with ligands directed against surface receptors of cells can enhance the targeting the immune system [56].”
- Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle (2013, background): “Apart from protein adsorption other minor differences in physicochemical characteristics such as zeta potential, and size of the NP surface have also been shown to influence their mode of uptake by cells [51,60-63].”
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. (2013, background): “Regardless of the mechanism by which PEG works and how well it improves PK and BD, significant RES clearance is still an issue, with typically >50% of the injected dose (ID) ending up in the liver and spleen after 48 h even for highly optimized PEGylated particles [13, 14, 26, 27].”
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. (2010, background): “The activation of the complement system and binding with the blood opsonins favored the particles larger than 500 nm in diameter, which resulted in the rapid clearance from the circulation system [1].”
- The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles (2011, neutral): “The physicochemical characteristics of NPs such as composition, particle size, surface charge and surface hydrophobicity may affect their interaction with plasma proteins (opsonins) and blood components (hematocompatibility), uptake and clearance by macrophages, and hence potentially influence their”
- Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence (2022, background): “The morphology of nanocarriers and their aggregation behavior are important factors for different biological properties, including their half-life, targeting efficiency and toxicity [39].”
- Delivery of siRNA Therapeutics: Barriers and Carriers (2010, background): “Endothelium in blood vessels can be classified as continuous (e.g., normal arteries, arterioles, capillaries), fenestrated (e.g., digestive mucosa), and discontinuous (e.g., liver) ( 41 ).”